Proscribe sold to Envision Pharma Group
APAC-based medical communications specialist ProScribe Pty Ltd has been acquired by innovative scientific communications and technology company, Envision Pharma Group, in a transaction managed by BCMS.
ProScribe Pty Ltd is a leading provider of medical writing services to pharmaceutical, biotechnology, device and academic organisations. Founded in 2000, ProScribe Pty Ltd expanded over a ten-year period from its Noosa, Queensland headquarters, establishing a presence in Sydney, Melbourne, Adelaide, Brisbane, Shanghai, and Tokyo.
The acquirer, UK-headquartered Envision Pharma Group, is a scientific communications and technology company, focused on the life sciences industry. Operating internationally from sites in the USA and UK, the group is also an industry leader in medical publication planning, execution, consultancy, and technology.